1-3 of 3
Paula M. Hale
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Bernard Zinman, MD, John Gerich, MD, John B. Buse, MD, PHD, Andrew Lewin, MD, Sherwyn Schwartz, MD, Philip Raskin, MD, Paula M. Hale, PHD, Milan Zdravkovic, PHD, Lawrence Blonde, MD, the LEAD-4 Study Investigators
Journal: Diabetes Care
Diabetes Care 2009;32(7):1224–1230
https://doi.org/10.2337/dc08-2124
Published: 16 March 2009
View article titled, Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Open the PDF for Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) in another window
Includes: Supplementary data
Journal Articles

Repaglinide Versus Nateglinide Monotherapy : A randomized, multicenter study

Julio Rosenstock, MD, David R. Hassman, DO, Robert D. Madder, DO, Shari A. Brazinsky, MD, James Farrell, MD, Naum Khutoryansky, PHD, Paula M. Hale, MD, for the Repaglinide Versus Nateglinide Comparison Study Group
Journal: Diabetes Care
Diabetes Care 2004;27(6):1265–1270
https://doi.org/10.2337/diacare.27.6.1265
Published: 01 June 2004
View article titled, Repaglinide Versus Nateglinide Monotherapy : <subtitle>A randomized, multicenter study </subtitle>
Open the PDF for Repaglinide Versus Nateglinide Monotherapy : <subtitle>A randomized, multicenter study </subtitle> in another window
Journal Articles

Efficacy and Safety of Combination Therapy: Repaglinide plus metformin versus nateglinide plus metformin

Philip Raskin, MD, Leslie Klaff, MD, Janet McGill, MD, Stephen A. South, MD, Priscilla Hollander, MD, Naum Khutoryansky, PHD, Paula M. Hale, MD, Repaglinide vs. Nateglinide Metformin Combination Study Group
Journal: Diabetes Care
Diabetes Care 2003;26(7):2063–2068
https://doi.org/10.2337/diacare.26.7.2063
Published: 01 July 2003
View article titled, Efficacy and Safety of Combination Therapy: <subtitle>Repaglinide plus metformin versus nateglinide plus metformin</subtitle>
Open the PDF for Efficacy and Safety of Combination Therapy: <subtitle>Repaglinide plus metformin versus nateglinide plus metformin</subtitle> in another window